Intrinsiqq

Iradimed Corp (IRMD) Dividend Analysis

Does Iradimed (IRMD) pay a dividend?

Yes. Iradimed (IRMD) pays a dividend: $1.23 per share over the last twelve months, a dividend yield of 1.49% at the latest close.

It has raised its dividend per share for at least 3 years in a row (every year of the history we hold), growing at 5.6% a year over the last 3 years. The payout takes about 68.7% of earnings.

Computed from SEC filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.

Dividend per share by fiscal year
Fiscal yearPer shareChange
2025$1.17+9.4%
2024$1.07+2.9%
2023$1.04+4.6%
2022$0.99

All 4 fiscal years we hold. Figures are adjusted for stock splits, so a fall is a cut.

IRMD
Dividend55
Low-yield dividend grower

Dividend is covered by FCF, though with limited buffer.

Based on TTM and annual data · Not a buy/sell signal

Score Breakdown

58

Safety

40% of composite

Earnings Payout50
68.7%Elevated
FCF Coverage65
1.6xAdequate
58

Growth

35% of composite

Dividend Streak45
3+YGrowing recently
Growth Rate70
5.6%Healthy growth
45

Income

25% of composite

Cash Yield (TTM)45
1.49%Below average

Composite = Safety (58) × 0.40 + Growth (58) × 0.35 + Income (45) × 0.25 = 55

Dividend Yield

1.49%

Per Share (TTM)

$1.23

Payout Ratio

68.7%

3Y CAGR

5.6%

Dividend Safety

Earnings Payout

68.7%

FCF Payout

63.0%

FCF Coverage

1.6x

Dividend Growth

Per Share (TTM)

$1.23

Growth Streak

3+ years

3Y CAGR

5.6%

Dividend Income

Annual DPS (TTM)

$1.23

Annual Income / $10K

$149

Payment frequency, ex-dividend and payment dates are not available from SEC filings. Check your broker or the company's investor relations page for the schedule.

Yield History

Iradimed (IRMD) dividend: yield, safety and growth

Frequently asked

Does Iradimed (IRMD) pay a dividend, and how much?+

Yes, Iradimed pays a regular dividend of about $1.23 per share per year (a yield of roughly 1.5%). That is a payout ratio of about 68.7% of earnings, so it is covered by free cash flow. A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.

Is Iradimed's dividend safe?+

Iradimed's dividend looks covered by free cash flow, with free cash flow covering the payout about 1.6 times over. Intrinsiqq scores its dividend safety at 58 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.

Has Iradimed grown its dividend?+

Iradimed has raised its dividend for at least 3 years in a row, the full span of the dividend history we hold. Over the past five years the dividend has grown at roughly 5.6% a year. Consistent growth is one of the strongest signals of a durable, shareholder-friendly business, so read the streak alongside coverage on this tab.

What is Iradimed's dividend payout ratio?+

Iradimed pays out about 68.7% of its earnings as dividends. A lower payout ratio leaves more room to keep raising the dividend and to absorb a bad year, while a very high ratio can signal a payout under pressure. On this measure the dividend is covered by free cash flow. See the dividend-safety breakdown for the free-cash-flow view, which is often more telling than earnings.

SourceDividend analysis computed from the 10-Q filed 31 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 1 Aug 2026. How this is calculated.

Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.

Related stocks: Surgical & Medical Instruments & Apparatus

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.